On December 3, 2024, the company announced groundbreaking results for its lead drug candidate, JANX007, a tumor-activated T-cell engager targeting advanced-stage prostate cancer.

U.S. stocks were mixed on Tuesday as investors digested new job openings data and awaited future remarks from Federal Reserve officials.

MicroStrategy has been making headlines once again, fueled by its audacious Bitcoin-centric strategy and a meteoric stock price rise of over 515% this year.

C3.ai, the enterprise AI software leader, has been at the center of attention on Reddit following its recent developments, which have sparked intense discussions about its future prospects.

U.S. stocks were mostly on an upswing as of midday Monday. The Dow Jones Industrial Average soared to intraday record highs as investors welcomed President-elect Donald Trump's choice of Scott Bessent as Treasury secretary.

The Russell 2000, the primary benchmark for small-cap stocks, soared to its highest level in three years, marking a significant turnaround for the index that is often overlooked compared to its large-cap counterparts.

Nvidia (NVDA) is set to report its third-quarter earnings this Wednesday after the market closes, offering an important and critical update on the strength of the artificial intelligence (AI) boom that has pushed the chipmaker to a meteoric rise in 2024.